In a recent publication, a Ukrainian hospital reports on the successful use of Adaptive Support Ventilation (ASV) to treat a 16-year old COVID-19 patient.
The patient was admitted to hospital with various symptoms, then transferred to the ICU some 6 days later after her condition worsened and she tested positive for COVID-19. A further 2 days later, the decision was made to intubate and ventilation was initiated in ASV mode on the HAMILTON-C1. According to the authors, the ventilator adapted successfully to spontaneous breathing attempts by the patient and her condition started to improve the next day.
After 5 days of ventilation, the decision was made to commence weaning and the patient was extubated that same day. The authors concluded that ASV was the mode of choice in viral pneumonia, as it provided protective ventilation and rapid weaning with a low risk of complications. This case report demonstrates the successful use of ASV from intubation to extubation not only in COVID-19, but also in a pediatric patient.
Dmytriiev D, Dobravanov O, Kralinsky K, et al. A CASE REPORT OF SUCCESSFUL EXPERIENCE OF USING ADAPTIVE SUPPORT VENTILATION IN THE PEDIATRIC PATIENT WITH VIRAL INTERSTITIAL PNEUMONIA COVID-19 POSITIVE Lek. Obzor, Bratislava: Herba, 2021, 70(3): 119-123.
The content of this article is for informational purposes only and is not intended to be a substitute for professional training or for standard treatment guidelines in your facility. Any recommendations made in this article with respect to clinical practice or the use of specific products, technology or therapies represent the personal opinion of the author only, and may not be considered as official recommendations made by Hamilton Medical AG. Hamilton Medical AG provides no warranty with respect to the information contained in this article and reliance on any part of this information is solely at your own risk.